| Literature DB >> 18193359 |
Abstract
Vasculitides represent such a heterogeneous group of disorders that difficulties arise in their classification. Although biopsy examination of involved tissues remains essential, new serological markers have been developed. Therapeutic strategies have been refined, and B lymphocyte-targeted drugs may prove a satisfactory alternative.Entities:
Mesh:
Year: 2008 PMID: 18193359 DOI: 10.1007/s12016-007-8061-y
Source DB: PubMed Journal: Clin Rev Allergy Immunol ISSN: 1080-0549 Impact factor: 8.667